Rothschild & Co Asset Management US’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $5.51M | Sell |
|
|||||
|
2021
Q4 | $6.67M | Buy |
|
|||||
|
2021
Q3 | $5.14M | Sell |
|
|||||
|
2021
Q2 | $9.11M | Sell |
|
|||||
|
2021
Q1 | $11M | Sell |
|
|||||
|
2020
Q4 | $17.6M | Sell |
|
|||||
|
2020
Q3 | $17.3M | Sell |
|
|||||
|
2020
Q2 | $17.7M | Sell |
|
|||||
|
2020
Q1 | $42.2M | Sell |
|
|||||
|
2019
Q4 | $44.7M | Sell |
|
|||||
|
2019
Q3 | $40.9M | Sell |
|
|||||
|
2019
Q2 | $41.2M | Sell |
|
|||||
|
2019
Q1 | $44.9M | Buy |
|
|||||
|
2018
Q4 | $42.6M | Sell |
|
|||||
|
2018
Q3 | $53.6M | Sell |
|
|||||
|
2018
Q2 | $38.2M | Buy |
|
|||||
|
2018
Q1 | $26.9M | Sell |
|
|||||
|
2017
Q4 | $23.9M | Sell |
|
|||||
|
2017
Q3 | $26.2M | Buy |
|
|||||
|
2017
Q2 | $27.7M | Buy |
|
|||||
|
2017
Q1 | $21.8M | Buy |
|
|||||
|
2016
Q4 | $17.5M | Buy |
|
|||||
|
2016
Q3 | $16.4M | Sell |
|
|||||
|
2016
Q2 | $17.7M | Buy |
|
|||||
|
2016
Q1 | $15.4M | Buy |
|
|||||
|
2015
Q4 | $10.4M | Buy |
|